Mixing compatibilities of Aspergillus and American cockroach allergens with other high-protease fungal and insect extracts.

[1]  W. Reisacher,et al.  A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy , 2012, International forum of allergy & rhinology.

[2]  R. Esch,et al.  Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  T. Grier How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  L. Cox,et al.  Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  R. Esch,et al.  Allergen compatibilities in extract mixtures. , 2011, Immunology and allergy clinics of North America.

[6]  S. Spector,et al.  Allergen immunotherapy: a practice parameter third update. , 2007, The Journal of allergy and clinical immunology.

[7]  H. Nelson Specific immunotherapy with allergen mixes: what is the evidence? , 2009, Current opinion in allergy and clinical immunology.

[8]  R. Esch,et al.  Stability and mixing compatibility of dog epithelia and dog dander allergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  A. Letz,et al.  T-cell epitopes of aeroallergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  M. Tankersley,et al.  Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  R. Esch Allergen immunotherapy: what can and cannot be mixed? , 2008, The Journal of allergy and clinical immunology.

[12]  V. Duschak,et al.  MALDI‐TOF MS analysis of labile Lolium perenne major allergens in mixes , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  R. Weber Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy. , 2008, The Journal of allergy and clinical immunology.

[14]  J. Bousquet,et al.  Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. , 2008, Clinical allergy and immunology.

[15]  Joint Task Force on Practice Parameters Allergen immunotherapy: a practice parameter second update. , 2007 .

[16]  R. Weber Cross-reactivity of pollen allergens: impact on allergen immunotherapy. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  R. Esch,et al.  Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  I. Bernstein Allergen immunotherapy: a practice parameter second update. , 2007, The Journal of allergy and clinical immunology.

[19]  M. Rathkopf,et al.  Effect of imported fire ant extract on the degradation of mountain cedar pollen allergen. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  L. Bernstein,et al.  Allergen immunotherapy: a practice parameter , 2003 .

[21]  L. Hagan,et al.  Factors affecting compliance with allergen immunotherapy at a military medical center. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[22]  R. Esch,et al.  Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics. , 2002, Allergy and asthma proceedings.

[23]  S. Vieths,et al.  Fusarium culmorum causes strong degradation of pollen allergens in extract mixtures. , 2002, The Journal of allergy and clinical immunology.

[24]  T. Grier Laboratory methods for allergen extract analysis and quality control , 2001, Clinical reviews in allergy & immunology.

[25]  L. Vailes,et al.  Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. , 2001, The Journal of allergy and clinical immunology.

[26]  B. Kurien,et al.  Multiple immunoblots after non-electrophoretic bidirectional transfer of a single SDS-PAGE gel with multiple antigens. , 1997, Journal of immunological methods.

[27]  J. Lamb,et al.  T-cell responses to allergens: epitope-specificity and clinical relevance. , 1996, Immunology today.

[28]  D. Ikle,et al.  Studies of allergen extract stability: the effects of dilution and mixing. , 1996, The Journal of allergy and clinical immunology.

[29]  J. Jones,et al.  Effect of mixing allergenic extracts containing Helminthosporium, D. farinae, and cockroach with perennial ryegrass. , 1993, Annals of allergy.

[30]  J. Salvaggio,et al.  Protease activity in cockroach and basidiomycete allergen extracts. , 1993, Allergy proceedings : the official journal of regional and state allergy societies.

[31]  J. Cohn,et al.  Determinants of patient compliance with allergen immunotherapy. , 1993, The Journal of allergy and clinical immunology.

[32]  R. Esch Role of proteases on the stability of allergenic extracts. , 1992, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.